As of 2024-12-15, the Relative Valuation of SpringWorks Therapeutics Inc (SWTX) is (99.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.30 USD, the upside of SpringWorks Therapeutics Inc based on Relative Valuation is -359.8%.
The range of the Relative Valuation is (101.94) - (104.90) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.6x - 40.2x | 34.4x |
| Forward P/E multiples | 19.0x - 28.4x | 19.4x |
| Fair Price | (101.94) - (104.90) | (99.50) |
| Upside | -366.2% - -373.9% | -359.8% |
| Date | P/E |
| 2024-11-20 | -10.12 |
| 2024-11-19 | -10.25 |
| 2024-11-18 | -9.34 |
| 2024-11-15 | -9.85 |
| 2024-11-14 | -9.88 |
| 2024-11-13 | -9.38 |
| 2024-11-12 | -8.95 |
| 2024-11-11 | -9.06 |
| 2024-11-08 | -9.19 |
| 2024-11-07 | -8.95 |
| 2024-11-06 | -8.92 |
| 2024-11-05 | -8.54 |
| 2024-11-04 | -8.36 |
| 2024-11-01 | -8.28 |
| 2024-10-31 | -8.15 |
| 2024-10-30 | -8.24 |
| 2024-10-29 | -8.15 |
| 2024-10-28 | -8.08 |
| 2024-10-25 | -7.92 |
| 2024-10-24 | -7.87 |
| 2024-10-23 | -7.73 |
| 2024-10-22 | -8.06 |
| 2024-10-21 | -8.24 |
| 2024-10-18 | -8.37 |
| 2024-10-17 | -8.32 |
| 2024-10-16 | -8.14 |
| 2024-10-15 | -8.25 |
| 2024-10-14 | -8.23 |
| 2024-10-11 | -8.29 |
| 2024-10-10 | -8.21 |
| 2024-10-09 | -8.38 |
| 2024-10-08 | -8.76 |
| 2024-10-07 | -8.72 |
| 2024-10-04 | -8.82 |
| 2024-10-03 | -8.61 |
| 2024-10-02 | -8.88 |
| 2024-10-01 | -8.71 |
| 2024-09-30 | -8.66 |
| 2024-09-27 | -8.73 |
| 2024-09-26 | -8.73 |
| 2024-09-25 | -8.79 |
| 2024-09-24 | -8.69 |
| 2024-09-23 | -8.89 |
| 2024-09-20 | -9.29 |
| 2024-09-19 | -9.56 |
| 2024-09-18 | -9.62 |
| 2024-09-17 | -9.58 |
| 2024-09-16 | -9.61 |
| 2024-09-13 | -10.12 |
| 2024-09-12 | -9.73 |